Cargando…

Specificity of CD8(+) T-Cell Responses Following Vaccination with Conserved Regions of HIV-1 in Nairobi, Kenya

Sub-Saharan Africa carries the biggest burden of the human immunodeficiency virus type 1 (HIV-1)/AIDS epidemic and is in an urgent need of an effective vaccine. CD8(+) T cells are an important component of the host immune response to HIV-1 and may need to be harnessed if a vaccine is to be effective...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohamed, Yehia S., Borthwick, Nicola J., Moyo, Nathifa, Murakoshi, Hayato, Akahoshi, Tomohiro, Siliquini, Francesca, Hannoun, Zara, Crook, Alison, Hayes, Peter, Fast, Patricia E., Mutua, Gaudensia, Jaoko, Walter, Silva-Arrieta, Sandra, Llano, Anuska, Brander, Christian, Takiguchi, Masafumi, Hanke, Tomáš
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7349992/
https://www.ncbi.nlm.nih.gov/pubmed/32485938
http://dx.doi.org/10.3390/vaccines8020260
_version_ 1783557183407915008
author Mohamed, Yehia S.
Borthwick, Nicola J.
Moyo, Nathifa
Murakoshi, Hayato
Akahoshi, Tomohiro
Siliquini, Francesca
Hannoun, Zara
Crook, Alison
Hayes, Peter
Fast, Patricia E.
Mutua, Gaudensia
Jaoko, Walter
Silva-Arrieta, Sandra
Llano, Anuska
Brander, Christian
Takiguchi, Masafumi
Hanke, Tomáš
author_facet Mohamed, Yehia S.
Borthwick, Nicola J.
Moyo, Nathifa
Murakoshi, Hayato
Akahoshi, Tomohiro
Siliquini, Francesca
Hannoun, Zara
Crook, Alison
Hayes, Peter
Fast, Patricia E.
Mutua, Gaudensia
Jaoko, Walter
Silva-Arrieta, Sandra
Llano, Anuska
Brander, Christian
Takiguchi, Masafumi
Hanke, Tomáš
author_sort Mohamed, Yehia S.
collection PubMed
description Sub-Saharan Africa carries the biggest burden of the human immunodeficiency virus type 1 (HIV-1)/AIDS epidemic and is in an urgent need of an effective vaccine. CD8(+) T cells are an important component of the host immune response to HIV-1 and may need to be harnessed if a vaccine is to be effective. CD8(+) T cells recognize human leukocyte antigen (HLA)-associated viral epitopes and the HLA alleles vary significantly among different ethnic groups. It follows that definition of HIV-1-derived peptides recognized by CD8(+) T cells in the geographically relevant regions will critically guide vaccine development. Here, we study fine details of CD8(+) T-cell responses elicited in HIV-1/2-uninfected individuals in Nairobi, Kenya, who received a candidate vaccine delivering conserved regions of HIV-1 proteins called HIVconsv. Using 10-day cell lines established by in vitro peptide restimulation of cryopreserved PBMC and stably HLA-transfected 721.221/C1R cell lines, we confirm experimentally many already defined epitopes, for a number of epitopes we define the restricting HLA molecule(s) and describe four novel HLA-epitope pairs. We also identify specific dominance patterns, a promiscuous T-cell epitope and a rescue of suboptimal T-cell epitope induction in vivo by its functional variant, which all together inform vaccine design.
format Online
Article
Text
id pubmed-7349992
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-73499922020-07-22 Specificity of CD8(+) T-Cell Responses Following Vaccination with Conserved Regions of HIV-1 in Nairobi, Kenya Mohamed, Yehia S. Borthwick, Nicola J. Moyo, Nathifa Murakoshi, Hayato Akahoshi, Tomohiro Siliquini, Francesca Hannoun, Zara Crook, Alison Hayes, Peter Fast, Patricia E. Mutua, Gaudensia Jaoko, Walter Silva-Arrieta, Sandra Llano, Anuska Brander, Christian Takiguchi, Masafumi Hanke, Tomáš Vaccines (Basel) Article Sub-Saharan Africa carries the biggest burden of the human immunodeficiency virus type 1 (HIV-1)/AIDS epidemic and is in an urgent need of an effective vaccine. CD8(+) T cells are an important component of the host immune response to HIV-1 and may need to be harnessed if a vaccine is to be effective. CD8(+) T cells recognize human leukocyte antigen (HLA)-associated viral epitopes and the HLA alleles vary significantly among different ethnic groups. It follows that definition of HIV-1-derived peptides recognized by CD8(+) T cells in the geographically relevant regions will critically guide vaccine development. Here, we study fine details of CD8(+) T-cell responses elicited in HIV-1/2-uninfected individuals in Nairobi, Kenya, who received a candidate vaccine delivering conserved regions of HIV-1 proteins called HIVconsv. Using 10-day cell lines established by in vitro peptide restimulation of cryopreserved PBMC and stably HLA-transfected 721.221/C1R cell lines, we confirm experimentally many already defined epitopes, for a number of epitopes we define the restricting HLA molecule(s) and describe four novel HLA-epitope pairs. We also identify specific dominance patterns, a promiscuous T-cell epitope and a rescue of suboptimal T-cell epitope induction in vivo by its functional variant, which all together inform vaccine design. MDPI 2020-05-29 /pmc/articles/PMC7349992/ /pubmed/32485938 http://dx.doi.org/10.3390/vaccines8020260 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Mohamed, Yehia S.
Borthwick, Nicola J.
Moyo, Nathifa
Murakoshi, Hayato
Akahoshi, Tomohiro
Siliquini, Francesca
Hannoun, Zara
Crook, Alison
Hayes, Peter
Fast, Patricia E.
Mutua, Gaudensia
Jaoko, Walter
Silva-Arrieta, Sandra
Llano, Anuska
Brander, Christian
Takiguchi, Masafumi
Hanke, Tomáš
Specificity of CD8(+) T-Cell Responses Following Vaccination with Conserved Regions of HIV-1 in Nairobi, Kenya
title Specificity of CD8(+) T-Cell Responses Following Vaccination with Conserved Regions of HIV-1 in Nairobi, Kenya
title_full Specificity of CD8(+) T-Cell Responses Following Vaccination with Conserved Regions of HIV-1 in Nairobi, Kenya
title_fullStr Specificity of CD8(+) T-Cell Responses Following Vaccination with Conserved Regions of HIV-1 in Nairobi, Kenya
title_full_unstemmed Specificity of CD8(+) T-Cell Responses Following Vaccination with Conserved Regions of HIV-1 in Nairobi, Kenya
title_short Specificity of CD8(+) T-Cell Responses Following Vaccination with Conserved Regions of HIV-1 in Nairobi, Kenya
title_sort specificity of cd8(+) t-cell responses following vaccination with conserved regions of hiv-1 in nairobi, kenya
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7349992/
https://www.ncbi.nlm.nih.gov/pubmed/32485938
http://dx.doi.org/10.3390/vaccines8020260
work_keys_str_mv AT mohamedyehias specificityofcd8tcellresponsesfollowingvaccinationwithconservedregionsofhiv1innairobikenya
AT borthwicknicolaj specificityofcd8tcellresponsesfollowingvaccinationwithconservedregionsofhiv1innairobikenya
AT moyonathifa specificityofcd8tcellresponsesfollowingvaccinationwithconservedregionsofhiv1innairobikenya
AT murakoshihayato specificityofcd8tcellresponsesfollowingvaccinationwithconservedregionsofhiv1innairobikenya
AT akahoshitomohiro specificityofcd8tcellresponsesfollowingvaccinationwithconservedregionsofhiv1innairobikenya
AT siliquinifrancesca specificityofcd8tcellresponsesfollowingvaccinationwithconservedregionsofhiv1innairobikenya
AT hannounzara specificityofcd8tcellresponsesfollowingvaccinationwithconservedregionsofhiv1innairobikenya
AT crookalison specificityofcd8tcellresponsesfollowingvaccinationwithconservedregionsofhiv1innairobikenya
AT hayespeter specificityofcd8tcellresponsesfollowingvaccinationwithconservedregionsofhiv1innairobikenya
AT fastpatriciae specificityofcd8tcellresponsesfollowingvaccinationwithconservedregionsofhiv1innairobikenya
AT mutuagaudensia specificityofcd8tcellresponsesfollowingvaccinationwithconservedregionsofhiv1innairobikenya
AT jaokowalter specificityofcd8tcellresponsesfollowingvaccinationwithconservedregionsofhiv1innairobikenya
AT silvaarrietasandra specificityofcd8tcellresponsesfollowingvaccinationwithconservedregionsofhiv1innairobikenya
AT llanoanuska specificityofcd8tcellresponsesfollowingvaccinationwithconservedregionsofhiv1innairobikenya
AT branderchristian specificityofcd8tcellresponsesfollowingvaccinationwithconservedregionsofhiv1innairobikenya
AT takiguchimasafumi specificityofcd8tcellresponsesfollowingvaccinationwithconservedregionsofhiv1innairobikenya
AT hanketomas specificityofcd8tcellresponsesfollowingvaccinationwithconservedregionsofhiv1innairobikenya